These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1358892)
1. Decreased tissue reaction to bioprosthetic heart valve material after L-glutamic acid treatment. A morphological study. Grabenwöger M; Grimm M; Eybl E; Leukauf C; Müller MM; Plenck H; Böck P J Biomed Mater Res; 1992 Sep; 26(9):1231-40. PubMed ID: 1358892 [TBL] [Abstract][Full Text] [Related]
2. Bioprosthetic cardiac valve degeneration: role of inflammatory and immune reactions. Gong G; Seifter E; Lyman WD; Factor SM; Blau S; Frater RW J Heart Valve Dis; 1993 Nov; 2(6):684-93. PubMed ID: 7719511 [TBL] [Abstract][Full Text] [Related]
3. Biocompatibility of aldehyde-fixed bovine pericardium. An in vitro and in vivo approach toward improvement of bioprosthetic heart valves. Grimm M; Eybl E; Grabenwöger M; Griesmacher A; Losert U; Böck P; Müller MM; Wolner E J Thorac Cardiovasc Surg; 1991 Aug; 102(2):195-201. PubMed ID: 1678026 [TBL] [Abstract][Full Text] [Related]
4. Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material. Grabenwöger M; Sider J; Fitzal F; Zelenka C; Windberger U; Grimm M; Moritz A; Böck P; Wolner E Ann Thorac Surg; 1996 Sep; 62(3):772-7. PubMed ID: 8784007 [TBL] [Abstract][Full Text] [Related]
5. Acidic glycoproteins accumulate in calcified areas of bioprosthetic tissue. Grabenwöger M; Böck P; Fitzal F; Schmidberger A; Grimm M; Laufer G; Bergmeister H; Wolner E J Heart Valve Dis; 1998 Mar; 7(2):229-34. PubMed ID: 9587867 [TBL] [Abstract][Full Text] [Related]
6. Detoxified glutaraldehyde cross-linked pericardium: tissue preservation and mineralization mitigation in a subcutaneous rat model. Valente M; Pettenazzo E; Thiene G; Molin GM; Martignago F; De Giorgi G; Gatti AM; Giaretta A; Pasquino E; Talenti E; Rinaldi S J Heart Valve Dis; 1998 May; 7(3):283-91. PubMed ID: 9651841 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of calcification with citric acid in pericardial bioprosthetic heart valve material: a preliminary report. Sucu N; Tamer L; Aytacoglu B; Polat A; Dondas HA; Gul A; Dikmengil M; Atik U J Heart Valve Dis; 2004 Jul; 13(4):697-700. PubMed ID: 15311880 [TBL] [Abstract][Full Text] [Related]
8. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model. Weissenstein C; Human P; Bezuidenhout D; Zilla P J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041 [TBL] [Abstract][Full Text] [Related]
9. Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential. Pathak CP; Adams AK; Simpson T; Phillips RE; Moore MA J Biomed Mater Res A; 2004 Apr; 69(1):140-4. PubMed ID: 14999761 [TBL] [Abstract][Full Text] [Related]
10. Initiation of mineralization in bioprosthetic heart valves: studies of alkaline phosphatase activity and its inhibition by AlCl3 or FeCl3 preincubations. Levy RJ; Schoen FJ; Flowers WB; Staelin ST J Biomed Mater Res; 1991 Aug; 25(8):905-35. PubMed ID: 1918108 [TBL] [Abstract][Full Text] [Related]
11. Two stage EDTA anti-calcification method for bioprosthetic heart valve materials. Sucu N; Karaca K; Yilmaz N; Cömelekoglu U; Aytacoglu BN; Tamer L; Ozeren M; Dondas HA; Oğuz Y; Ogenler O; Dikmengil M Med Sci Monit; 2006 Jun; 12(6):MT33-8. PubMed ID: 16733494 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid grafting mitigates calcification of glutaraldehyde-fixed bovine pericardium. Ohri R; Hahn SK; Hoffman AS; Stayton PS; Giachelli CM J Biomed Mater Res A; 2004 Aug; 70(2):328-34. PubMed ID: 15227678 [TBL] [Abstract][Full Text] [Related]
13. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies. Vyavahare NR; Jones PL; Hirsch D; Schoen FJ; Levy RJ J Heart Valve Dis; 2000 Jul; 9(4):561-6. PubMed ID: 10947050 [TBL] [Abstract][Full Text] [Related]
14. Onset and progression of experimental bioprosthetic heart valve calcification. Schoen FJ; Levy RJ; Nelson AC; Bernhard WF; Nashef A; Hawley M Lab Invest; 1985 May; 52(5):523-32. PubMed ID: 3990244 [TBL] [Abstract][Full Text] [Related]
15. Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model. Pettenazzo E; Valente M; Thiene G Eur J Cardiothorac Surg; 2008 Aug; 34(2):418-22. PubMed ID: 18550382 [TBL] [Abstract][Full Text] [Related]
16. Endothelial cell lining of bioprosthetic heart valve materials. Eybl E; Grimm M; Grabenwöger M; Böck P; Müller MM; Wolner E J Thorac Cardiovasc Surg; 1992 Sep; 104(3):763-9. PubMed ID: 1355151 [TBL] [Abstract][Full Text] [Related]
17. A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification. Zhou J; Jiang H; Wang D; Hu S J Heart Valve Dis; 2009 Mar; 18(2):180-5; discussion 186. PubMed ID: 19455893 [TBL] [Abstract][Full Text] [Related]
18. Histological evaluation of biocompatibility of lyophilized bovine pericardium implanted subcutaneously in rats. Maizato MJ; Pires MD; Canzian M; Higa OZ; Pitombo RN; Leirner AA Artif Organs; 2008 Apr; 32(4):268-71. PubMed ID: 18370939 [TBL] [Abstract][Full Text] [Related]
19. Diamine-extended glutaraldehyde- and carbodiimide crosslinks act synergistically in mitigating bioprosthetic aortic wall calcification. Zilla P; Bezuidenhout D; Torrianni M; Hendriks M; Human P J Heart Valve Dis; 2005 Jul; 14(4):538-45. PubMed ID: 16116882 [TBL] [Abstract][Full Text] [Related]
20. Glutaraldehyde affects biocompatibility of bioprosthetic heart valves. Grimm M; Eybl E; Grabenwöger M; Spreitzer H; Jäger W; Grimm G; Böck P; Müller MM; Wolner E Surgery; 1992 Jan; 111(1):74-8. PubMed ID: 1728078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]